Literature DB >> 15066958

Endogenous diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate in human myocardial tissue.

Jiankai Luo1, Vera Jankowski, Nihayrt Güngär, Joachim Neumann, Wilhelm Schmitz, Walter Zidek, Hartmut Schlüter, Joachim Jankowski.   

Abstract

Diadenosine polyphosphates have been characterized as extracellular mediators controlling numerous physiological effects. In this study, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate were isolated and identified in human myocardial tissue. Human myocardial tissue was homogenized and fractionated by affinity chromatography, displacement chromatography, anion-exchange chromatography, and reversed-phase chromatography. In fractions purified to homogeneity, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate were revealed by matrix-assisted laser desorption/ionization mass spectrometry and ultraviolet spectroscopy. These diadenosine polyphosphates were further identified by enzymatic analysis, which demonstrated an interconnection of the phosphate groups with the adenosines in the 5' positions of the riboses. Furthermore, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate were found in human cardiac-specific granules, and the amount of diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate was estimated in the range of approximately 500 micromol/L. In conclusion, the experiments show that the diadenosine polyphosphates with 2 and 3 phosphate groups occur in human myocardial tissue, and so do the diadenosine polyphosphates with 4 to 6 phosphate groups. After being released by cholinergic stimulation, which is known to affect diadenosine polyphosphate release from secretory granules, diadenosine tetraphosphate, diadenosine pentaphosphate, and diadenosine hexaphosphate activate P2X purinoceptors in vascular smooth muscle; hence, they can act as vasoconstrictors. It may be inferred that the differential action of both predominantly vasodilator and vasoconstrictor diadenosine polyphosphates allow a fine-tuning of myocardial blood flow by locally released diadenosine polyphosphates.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15066958     DOI: 10.1161/01.hyp.0000126110.46402.dd

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  One-flask synthesis of dinucleoside tetra- and pentaphosphates.

Authors:  Qianwei Han; Barbara L Gaffney; Roger A Jones
Journal:  Org Lett       Date:  2006-05-11       Impact factor: 6.005

2.  Effects of diadenosine polyphosphates on glomerular volume.

Authors:  Miroslawa Szczepańska-Konkel; Maciej Jankowski; Anna Stiepanow-Trzeciak; Stefan Angielski
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

Review 3.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

4.  Endogenous coenzyme A glutathione disulfide in human myocardial tissue.

Authors:  J Luo; V Jankowski; L Henning; H Schlüter; W Zidek; J Jankowski
Journal:  J Endocrinol Invest       Date:  2006-09       Impact factor: 4.256

5.  Diadenosine tetra- and pentaphosphates affect contractility and bioelectrical activity in the rat heart via P2 purinergic receptors.

Authors:  Ksenia B Pustovit; Vladislav S Kuzmin; Denis V Abramochkin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-17       Impact factor: 3.000

6.  Diadenosine pentaphosphate affects electrical activity in guinea pig atrium via activation of potassium acetylcholine-dependent inward rectifier.

Authors:  Denis V Abramochkin; Viktoria M Karimova; Tatiana S Filatova; Andre Kamkin
Journal:  J Physiol Sci       Date:  2016-12-10       Impact factor: 2.781

7.  Diadenosine pentaphosphate is a potent activator of cardiac ryanodine receptors revealing a novel high-affinity binding site for adenine nucleotides.

Authors:  L Song; S M Carter; Y Chen; R Sitsapesan
Journal:  Br J Pharmacol       Date:  2009-02-13       Impact factor: 8.739

8.  Nucleoside Tetra- and Pentaphosphates Prepared Using a Tetraphosphorylation Reagent Are Potent Inhibitors of Ribonuclease A.

Authors:  Scott M Shepard; Ian W Windsor; Ronald T Raines; Christopher C Cummins
Journal:  J Am Chem Soc       Date:  2019-11-11       Impact factor: 15.419

9.  Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate.

Authors:  V Jankowski; A Patzak; S Herget-Rosenthal; Thi Nguyet Anh Tran; En Yin Lai; T Günthner; I Buschmann; W Zidek; J Jankowski
Journal:  J Mol Med (Berl)       Date:  2008-02-05       Impact factor: 4.599

10.  Transient and persistent metabolomic changes in plasma following chronic cigarette smoke exposure in a mouse model.

Authors:  Charmion I Cruickshank-Quinn; Spencer Mahaffey; Matthew J Justice; Grant Hughes; Michael Armstrong; Russell P Bowler; Richard Reisdorph; Irina Petrache; Nichole Reisdorph
Journal:  PLoS One       Date:  2014-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.